Items where authors include "FitzGerald, O"

Export as [feed] Atom [feed] RSS
Number of items: 37.

Article

Orbai, A-M, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (4 more authors) (2022) Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. BMC Rheumatology, 6 (1). 68. ISSN 2520-1026

Soomro, M, Stadler, M, Dand, N et al. (60 more authors) (2022) Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling. Arthritis and Rheumatology, 74 (9). pp. 1535-1543. ISSN 2326-5191

Coates, LC, Soriano, ER, Corp, N et al. (42 more authors) (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews Rheumatology, 18 (8). pp. 465-479. ISSN 1759-4790

Coates, LC, Baraliakos, X, Blanco, FJ et al. (17 more authors) (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status? Arthritis Care & Research, 73 (6). pp. 856-860. ISSN 2151-464X

Goel, N, Coates, LC orcid.org/0000-0002-4756-663X, De Marco, G orcid.org/0000-0003-2406-161X et al. (11 more authors) (2020) GRAPPA 2019 Project Report. The Journal of Rheumatology Supplement, 96. pp. 53-57. ISSN 0380-0903

Goel, N, FitzGerald, O, Gladman, DD et al. (6 more authors) (2019) GRAPPA 2018 Project Report. The Journal of Rheumatology Supplement, 95. pp. 54-57. ISSN 0380-0903

Jadon, DR, Chandran, V, Ogdie, A et al. (12 more authors) (2019) Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology Supplement, 95. pp. 11-19. ISSN 0380-0903

Abraham, S, Barton, A, Eder, L et al. (10 more authors) (2019) Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) Meeting. Seminars in Arthritis and Rheumatism, 48 (6). pp. 1005-1013. ISSN 0049-0172

De Marco, G, McGonagle, D, Mathieson, HR et al. (5 more authors) (2018) Combined inhibition of tumour necrosis factor-alpha and interleukin-12/23 for long-standing, refractory psoriatic disease: a differential role for cytokine pathways? Rheumatology, 57 (11). pp. 2053-2055. ISSN 1462-0324

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease. Arthritis Research and Therapy, 20. 242. ISSN 1478-6354

Coates, LC orcid.org/0000-0002-4756-663X, Conaghan, PG orcid.org/0000-0002-3478-5665, D’Agostino, MA et al. (9 more authors) (2018) Remission in psoriatic arthritis—where are we now? Rheumatology, 57 (8). pp. 1321-1331. ISSN 1462-0324

Jadon, DR, Chandran, V, Stober, C et al. (9 more authors) (2018) Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology, 94 (S). pp. 54-61. ISSN 0380-0903

Højgaard, P, Klokker, L, Orbai, A-M et al. (17 more authors) (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism, 47 (5). pp. 654-665. ISSN 0049-0172

Coates, LC orcid.org/0000-0002-4756-663X, FitzGerald, O, Merola, JF et al. (23 more authors) (2018) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Arthritis & Rheumatology, 70 (3). pp. 345-355. ISSN 2326-5191

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Tillett, W, Dures, E, Hewlett, S et al. (9 more authors) (2017) A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis. The Journal of Rheumatology, 44 (10). pp. 1445-1452. ISSN 0315-162X

Bowes, J, Ashcroft, J, Dand, N et al. (19 more authors) (2017) Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis. Annals of the Rheumatic Diseases, 76 (10). pp. 1774-1779. ISSN 0003-4967

Helliwell, PS, FitzGerald, O, Coates, LC et al. (2 more authors) (2017) GRAPPA 2016 Project Report. The Journal of Rheumatology, 44 (5). pp. 706-710. ISSN 0315-162X

Jadon, DR, Gladman, DD, Mease, PJ et al. (19 more authors) (2017) Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology, 44 (5). pp. 668-673. ISSN 0315-162X

Coates, LC orcid.org/0000-0002-4756-663X, FitzGerald, O, Helliwell, PS et al. (1 more author) (2016) Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? Seminars in Arthritis and Rheumatism, 46 (3). pp. 291-304. ISSN 0049-0172

Mease, PJ, Helliwell, PS, Boehncke, W-H et al. (5 more authors) (2016) GRAPPA 2015 Research and Education Project Reports. The Journal of Rheumatology, 43 (5). pp. 979-985. ISSN 0315-162X

Orbai, A-M, Mease, PJ, de Wit, M et al. (15 more authors) (2016) Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 965-969. ISSN 0315-162X

Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967

Bowes, J, Loehr, S, Budu-Aggrey, A et al. (21 more authors) (2015) PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus. Annals of the Rheumatic Diseases, 74 (10). pp. 1882-1885. ISSN 0003-4967

Bowes, J, Budu-Aggrey, A, Huffmeier, U et al. (29 more authors) (2015) Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nature Communications, 6. 6046. ISSN 2041-1723

Helliwell, PS, FitzGerald, O, Fransen, J et al. (34 more authors) (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Annals of the Rheumatic Diseases, 72 (6). pp. 986-991. ISSN 1468-2060

Bowes, J, Ho, P, Flynn, E et al. (14 more authors) (2012) Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases, 71 (8). pp. 1350-1354. ISSN 0003-4967

Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967

Bowes, J, Orozco, G, Flynn, E et al. (14 more authors) (2011) Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Annals of the Rheumatic Diseases, 70 (9). pp. 1641-1644. ISSN 0003-4967

Bowes, J, Eyre, S, Flynn, E et al. (17 more authors) (2011) Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases, 70 (6). pp. 1016-1019. ISSN 0003-4967

Conference or Workshop Item

Mease, P, Orbai, A-M, FitzGerald, O et al. (5 more authors) (2021) Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Orbai, A-M, Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2020) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Helliwell, P, Bushmakin, A, Gladman, D et al. (5 more authors) (2019) Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Coates, L, Bushmakin, A, FitzGerald, O et al. (5 more authors) (2019) Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. In: Pan-American League of Rheumatology Associations (PANLAR) Congress 2018, 07-10 Apr 2018, Buenos Aires, Argentina.

Proceedings Paper

Duarte-Garcia, A, Eder, L, Stephens-Shields, A et al. (13 more authors) (2018) Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Gromer, D, Coates, LC, FitzGerald, O et al. (3 more authors) (2018) Identification of Treatment Naïve Patients with Psoriatic Arthritis Who Will Require a TNF Inhibitor. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

This list was generated on Sat Mar 23 16:43:16 2024 GMT.